Blood Test Detects Aggressive Brain Tumors Early and Could Reduce Need for Risky Surgery

Researchers at the University of Sussex, led by Professor Georgios Giamas, have identified a blood test capable of early diagnosis of glioblastoma, one of the most aggressive forms of brain cancer. Working with international scientists, the team discovered distinctive biomarkers in patient blood samples that signal the presence of glioblastoma. The breakthrough technology could eliminate the need for dangerous surgical biopsies currently required for diagnosis, potentially saving lives through earlier detection and reduced procedural risks. The development represents a significant advance in diagnosing this deadly brain tumor through a minimally invasive blood-based approach.

Blood Test Technology for Glioblastoma Detection

• ▪Professor Georgios Giamas is the lead author of the University of Sussex glioblastoma blood test research.
• ▪The University of Sussex research was conducted in collaboration with scientists from different institutes worldwide.
• ▪Glioblastoma is one of the most aggressive forms of brain tumor.
• ▪Professor Georgios Giamas and his team identified distinctive biomarkers within patient blood samples that could signal the presence of glioblastoma.
• ▪Researchers at the University of Sussex have identified a blood test capable of early diagnosis of glioblastoma.

Potential Clinical Impact and Benefits

• ▪The University of Sussex blood test for glioblastoma could reduce the need for risky surgery.
• ▪The University of Sussex blood test technology for glioblastoma has the potential to save lives.

Perspective of Professor Georgios Giamas and University of Sussex research team

• ▪The distinctive biomarkers identified by Professor Georgios Giamas's team enable early detection of glioblastoma through blood samples.
• ▪The University of Sussex blood test could eliminate the need for dangerous surgical biopsies for glioblastoma diagnosis.

Perspective of Glioblastoma patients and families

• ▪Early diagnosis of glioblastoma through the University of Sussex blood test could improve patient survival prospects.
• ▪The University of Sussex blood test offers glioblastoma patients a less dangerous diagnostic option compared to surgical biopsies.

1 source